Cavendish Conference Centre, 22 Duchess Mews, London W1G 9DT

Chairs: Dr George Follows (Cambridge) and Professor Graham Jackson (Newcastle)


CLL – heading for a cure?
Continuous therapy in myeloma – the future
The impact of the new licensed therapies in AML
MPN / MF update
High risk and resistant CML: new diagnostic tools and treatment approaches


ECHELON 1 : Brentuximab should be used first line in advanced Hodgkin lymphoma
GALLIUM : Obinutuzumab, not rituximab, should be used first line for patients with symptomatic follicular lymphoma

Confirmed Speakers:

  • Dr Mike Dennis (Christie Hospital, Manchester)
  • Dr George Follows (Addenbrooke’s Hospital, Cambridge)
  • Professor Tim Illidge (Christie Hospital, Manchester)
  • Professor Graham Jackson (NCCC, Newcastle)
  • Dr Graham Collins (Oxford University Hospitals)
  • Dr Wendy Osborne (Freeman Hospital, Newcastle)
  • Dr Hugues de Lavallade (King’s College Hospital, London)
  • Professor Claire Harrison (Guy’s and St Thomas’ Hospital, London)

Registration Fees:

(inclusive of VAT @ 20%)


Trainees / Nurses*

 Standard Fee (until 19th June)



 Late Fee (from 20th June)




* 20 free places available for Trainees & Nurses (allocated on a first-come, first-served basis – please email to check availability)


Registration questions:
Sponsorship opportunities: